Outcomes | Perindopril + indapamide | Double placebo | RRR (95% CI) | NNT (CI) |
---|---|---|---|---|
Stroke | 8.5% | 14% | 43% (30 to 54) | 17 (13 to 27) |
Major vascular events | 13% | 21% | 40% (29 to 49) | 14 (10 to 20) |
Outcomes | Perindopril alone | Single placebo | RRR (CI) | NNT |
---|---|---|---|---|
§Abbreviations defined in glossary; NNT and CI calculated from data in article. | ||||
Stroke | 12.3% | 12.9% | 5% (–19 to 23) | Not significant |
Major vascular events | 17.7% | 18.5% | 4% (–15 to 20) | Not significant |